Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Young female cancer survivors' use of fertility care after completing cancer treatment.

Kim J, Mersereau JE, Su HI, Whitcomb BW, Malcarne VL, Gorman JR.

Support Care Cancer. 2016 Mar 4. [Epub ahead of print]

PMID:
26939923
2.

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Dominick S, Hickey M, Chin J, Su HI.

Cochrane Database Syst Rev. 2015 Dec 9;12:CD007245. doi: 10.1002/14651858.CD007245.pub3. Review.

PMID:
26649916
3.

No gynecologist in town: the gynecological care of women in rural Taiwan.

Lai LJ, Chou CL, Su HI, Chen TJ, Chou LF, Chou YC, Hwang SJ, Yu HC.

Patient Prefer Adherence. 2015 Jul 29;9:1077-83. doi: 10.2147/PPA.S64731. eCollection 2015.

4.

Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.

Dominick SA, McLean MR, Whitcomb BW, Gorman JR, Mersereau JE, Bouknight JM, Su HI.

Obstet Gynecol. 2015 Sep;126(3):498-507. doi: 10.1097/AOG.0000000000000963.

PMID:
26181090
5.

Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitors.

Brier MJ, Chambless D, Gross R, Su HI, DeMichele A, Mao JJ.

Eur J Cancer. 2015 Sep;51(14):1890-6. doi: 10.1016/j.ejca.2015.06.113. Epub 2015 Jul 10.

PMID:
26169018
6.

Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency.

Boland BS, Widjaja CE, Banno A, Zhang B, Kim SH, Stoven S, Peterson MR, Jones MC, Su HI, Crowe SE, Bui JD, Ho SB, Okugawa Y, Goel A, Marietta EV, Khosroheidari M, Jepsen K, Aramburu J, López-Rodríguez C, Sandborn WJ, Murray JA, Harismendy O, Chang JT.

J Immunol. 2015 Mar 15;194(6):2551-60. doi: 10.4049/jimmunol.1401463. Epub 2015 Feb 9.

7.

Ethical considerations for informed consent in infertility research: The use of electronic health records.

Wells KJ, Gordon JR, Su HI, Plosker S, Quinn GP.

Adv Med Ethics. 2015;2. pii: 7. Epub 2015 Dec 21.

8.

Experiencing reproductive concerns as a female cancer survivor is associated with depression.

Gorman JR, Su HI, Roberts SC, Dominick SA, Malcarne VL.

Cancer. 2015 Mar 15;121(6):935-42. doi: 10.1002/cncr.29133. Epub 2014 Nov 6.

9.

Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.

Maas KH, Chuan SS, Cook-Andersen H, Su HI, Duleba A, Chang RJ.

J Clin Endocrinol Metab. 2015 Jan;100(1):293-300. doi: 10.1210/jc.2014-2956.

10.

Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.

Cook-Andersen H, Chuan SS, Maas K, Rosencrantz MA, Su HI, Lawson M, Mason HD, Chang RJ.

J Clin Endocrinol Metab. 2015 Jan;100(1):251-7. doi: 10.1210/jc.2014-2948.

11.

The ecology of gynecological care for women.

Chang CP, Chou CL, Chou YC, Shao CC, Su HI, Chen TJ, Chou LF, Yu HC.

Int J Environ Res Public Health. 2014 Jul 31;11(8):7669-77. doi: 10.3390/ijerph110807669.

12.

A Diversified Recruitment Approach Incorporating Social Media Leads to Research Participation Among Young Adult-Aged Female Cancer Survivors.

Gorman JR, Roberts SC, Dominick SA, Malcarne VL, Dietz AC, Su HI.

J Adolesc Young Adult Oncol. 2014 Jun 1;3(2):59-65.

13.

Factors associated with pregnancy attempts among female young adult cancer survivors.

Dominick SA, Whitcomb BW, Gorman JR, Mersereau JE, Chung K, Su HI.

J Cancer Surviv. 2014 Dec;8(4):571-9. doi: 10.1007/s11764-014-0369-z. Epub 2014 May 24.

14.

Comparability of antimüllerian hormone levels among commercially available immunoassays.

Su HI, Sammel MD, Homer MV, Bui K, Haunschild C, Stanczyk FZ.

Fertil Steril. 2014 Jun;101(6):1766-72.e1. doi: 10.1016/j.fertnstert.2014.02.046. Epub 2014 Apr 14.

15.

Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization.

Chuan S, Homer M, Pandian R, Conway D, Garzo G, Yeo L, Su HI.

Fertil Steril. 2014 Feb;101(2):392-8. doi: 10.1016/j.fertnstert.2013.11.003. Epub 2013 Dec 17.

16.

A multidimensional scale to measure the reproductive concerns of young adult female cancer survivors.

Gorman JR, Su HI, Pierce JP, Roberts SC, Dominick SA, Malcarne VL.

J Cancer Surviv. 2014 Jun;8(2):218-28. doi: 10.1007/s11764-013-0333-3. Epub 2013 Dec 19.

17.

Endogenous estradiol is not associated with poor physical health in postmenopausal breast cancer survivors.

Su HI, Sue LY, Flatt SW, Natarajan L, Patterson RE, Pierce JP.

J Womens Health (Larchmt). 2013 Dec;22(12):1043-8. doi: 10.1089/jwh.2013.4375. Epub 2013 Oct 10.

18.

The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women.

Su HI, Maas K, Sluss PM, Chang RJ, Hall JE, Joffe H.

J Clin Endocrinol Metab. 2013 Dec;98(12):E1961-6. doi: 10.1210/jc.2013-2410. Epub 2013 Sep 30.

19.

To preserve or not to preserve: how difficult is the decision about fertility preservation?

Mersereau JE, Goodman LR, Deal AM, Gorman JR, Whitcomb BW, Su HI.

Cancer. 2013 Nov 15;119(22):4044-50. doi: 10.1002/cncr.28317. Epub 2013 Aug 26.

20.

Reply of the authors.

Meldrum DR, Fisher AR, Butts SF, Su HI, Sammel MD.

Fertil Steril. 2013 Oct;100(4):e22. doi: 10.1016/j.fertnstert.2013.07.1971. Epub 2013 Aug 8. No abstract available.

PMID:
23932817
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk